JCM, Vol. 13, Pages 2463: Diagnostic, Theranostic and Prognostic Value of Thyroglobulin in Thyroid Cancer

Thyroglobulin (Tg) is an iodinated glycoprotein, which is normally stored in the follicular colloid of the thyroid, being a substrate for thyroid hormone production. Since it is produced by well-differentiated thyroid cells, it is considered a reliable tumor marker for patients with differentiated thyroid carcinoma (DTC) during their follow-up after total thyroidectomy and radioiodine ablation. It is used to monitor residual disease and to detect recurrent disease. After total thyroid ablation, unstimulated highly sensitive Tg measurements are sufficiently accurate to avoid exogenous or endogenous thyrotropin (TSH) stimulation and provide accurate diagnostic and prognostic information in the great majority of DTC patients. Adopting sophisticated statistical analysis, i.e., decision tree models, the use of Tg before radioiodine theranostic administration was demonstrated to be useful in refining conventional, pathology-based risk stratification and providing personalized adjuvant or therapeutic radioiodine administrations. The follow-up of DTC patients aims to promptly identify patients with residual or recurrent disease following primary treatment. Our review paper covers the diagnostic, theranostic and prognostic value of thyroglobulin in DTC patients.

Apr 23, 2024 - 21:11
 0  135
JCM, Vol. 13, Pages 2463: Diagnostic, Theranostic and Prognostic Value of Thyroglobulin in Thyroid Cancer

JCM, Vol. 13, Pages 2463: Diagnostic, Theranostic and Prognostic Value of Thyroglobulin in Thyroid Cancer

Journal of Clinical Medicine doi: 10.3390/jcm13092463

Authors: Luca Giovanella Federica D’Aurizio Petra Petranović Ovčariček Rainer Görges

Thyroglobulin (Tg) is an iodinated glycoprotein, which is normally stored in the follicular colloid of the thyroid, being a substrate for thyroid hormone production. Since it is produced by well-differentiated thyroid cells, it is considered a reliable tumor marker for patients with differentiated thyroid carcinoma (DTC) during their follow-up after total thyroidectomy and radioiodine ablation. It is used to monitor residual disease and to detect recurrent disease. After total thyroid ablation, unstimulated highly sensitive Tg measurements are sufficiently accurate to avoid exogenous or endogenous thyrotropin (TSH) stimulation and provide accurate diagnostic and prognostic information in the great majority of DTC patients. Adopting sophisticated statistical analysis, i.e., decision tree models, the use of Tg before radioiodine theranostic administration was demonstrated to be useful in refining conventional, pathology-based risk stratification and providing personalized adjuvant or therapeutic radioiodine administrations. The follow-up of DTC patients aims to promptly identify patients with residual or recurrent disease following primary treatment. Our review paper covers the diagnostic, theranostic and prognostic value of thyroglobulin in DTC patients.

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Lema Kefyalew Studying a Ph.D. in Civil Engineering (Hydraulic Engineering). Studying Master of Project Management (MPM). Graduated with MSc in Civil Engineering (Hydraulic Engineering). Followed a 12 month Software Engineering program at ALX_Africa (Holberton school). Graduated with BA degree in Management. Graduated with BSc degree in Civil Engineering.